“I am asking county departments to stop the use of this herbicide until public health and environmental professionals can determine if it’s safe for further use in L.A. County and explore alternative methods for vegetation management,” Kathryn Barger of the Los Angeles County Board of Supervisors said.
The motion follows a San Francisco court’s ruling that Roundup was a “substantial factor” in 70-year-old Edwin Hardeman’s non-Hodgkin’s lymphoma, which he developed after using the herbicide on his Sonoma property for decades. The verdict was the second such unfavorable ruling for Germany’s Bayer, which was fortunate enough to acquire Monsanto just last year.
With legal responsibility no longer falling on Americans' shoulders, a California court awarded plaintiff Dewayne Johnson $289 million last August, ruling the popular herbicide also caused his non-Hodgkins lymphoma. The payout was later reduced to $78 million, but it opened the floodgates for upwards of 9,300 similar lawsuits against Bayer.
While the supervisory board motion doesn’t mention the recent court verdicts, it does cite “a growing body of scientific study” suggesting glyphosate’s carcinogenicity and asks the Department of Public Works to look into possible alternatives and deliver a report with recommendations within 30 days.
A group of scientists with links to the Environmental Protection Agency found individuals heavily exposed to Roundup had an appalling 41 percent higher risk of developing non-Hodgkins lymphoma than unexposed individuals in a study published earlier this year, and the US regulator is currently reviewing its 2016 study that found the weed killer had “low toxicity for humans.”
The World Health Organization found in an 11-country 2015 study that glyphosate is “probably carcinogenic to humans,” while California added the substance to its list of chemicals “known to cause cancer” in 2017. Bayer maintains that the product they acquired with the Monsanto brand is safe.
A U.S. jury on Tuesday found Bayer AG’s glyphosate-based Roundup weed killer caused cancer, a blow to the company eight months after another jury issued a $289 million verdict over similar claims in a different case.
German chemicals and pharmaceuticals giant Bayer is set to face a second US trial over allegations that its glyphosate-based weed killer Roundup causes cancer. This is six months after the company was rocked by a $289-million verdict by a California state court.
A far-reaching new scientific analysis found that the weed-killing chemical glyphosate is far more dangerous than U.S. government officials admit, showing a 41 percent increased risk of developing cancer for people who have frequent exposure.
Our IP Address: